Migergot is a Rectal Suppository in the Human Prescription Drug category. It is labeled and distributed by Horizon Pharma Inc.. The primary component is Ergotamine Tartrate; Caffeine.
Product ID | 75987-090_eb79b0e8-07d8-478d-80a8-65bc9476e1b3 |
NDC | 75987-090 |
Product Type | Human Prescription Drug |
Proprietary Name | Migergot |
Generic Name | Ergotamine Tartrate And Caffeine |
Dosage Form | Suppository |
Route of Administration | RECTAL |
Marketing Start Date | 1983-10-30 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA086557 |
Labeler Name | Horizon Pharma Inc. |
Substance Name | ERGOTAMINE TARTRATE; CAFFEINE |
Active Ingredient Strength | 2 mg/1; mg/1 |
Pharm Classes | Ergotamine Derivative [EPC],Ergotamines [CS],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 1983-10-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA086557 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1983-10-30 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
ERGOTAMINE TARTRATE | 2 mg/1 |
SPL SET ID: | 4ae331e0-009a-477e-8408-6118dc620634 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0713-0166 | MIGERGOT | Ergotamine Tartrate and Caffeine |
75987-090 | Migergot | ergotamine tartrate and caffeine |
0781-5405 | Cafergot | Ergotamine Tartrate and Caffeine |
0143-2120 | ERGOTAMINE | ergotamine tartrate and caffeine |
24470-917 | ergotamine tartrate and caffeine | ergotamine tartrate and caffeine |
46672-198 | ergotamine tartrate and caffeine | ergotamine tartrate and caffeine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
MIGERGOT 73720378 1508914 Live/Registered |
G&W LABORATORIES, INC. 1988-04-04 |